Synergy Financial Management »

Inhibikase Therapeutics shares owned by Synergy Financial Management

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Synergy Financial Management from 13F filings

Historical chart of Synergy Financial Management investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Synergy Financial Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Synergy Financial Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $65 50 1.30